#MarketswithMC | Infosys opened in the green on July 15, a day after declaring its #Q1 results. Here is what brokerages have to say about the stock: https://www.moneycontrol.com/news/business/stocks/what-should-investors-do-with-infosys-after-q1-results-buy-sell-or-hold-7174951.html?utm_source=telegram&utm_medium=social
Moneycontrol
What Should Investors Do With Infosys After Q1 Results: Buy, Sell Or Hold?
The country's second-largest software services provider Infosys reported a consolidated net profit of Rs 5,195 crore for the quarter ended June 2021, thereby growing 2.3 percent sequentially. However, the company increased its full-year revenue growth forecast…
#Q1: Although things are looking up for the Centre on the revenue front, some concerns remain, especially on disinvestment.
https://www.moneycontrol.com/news/business/economy/analysis-after-q1-centres-revenue-position-looks-comfortable-divestment-concerns-remain-7228491.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/business/economy/analysis-after-q1-centres-revenue-position-looks-comfortable-divestment-concerns-remain-7228491.html?utm_source=telegram&utm_medium=social
Moneycontrol
Analysis | After Q1, Centre’s Revenue Position Looks Comfortable; Divestment Concerns Remain
The first quarter has been relatively encouraging on the tax and non-tax revenue front, and the Centre’s fiscal position is comfortable for now, even with additional expenditure. However, the government needs to pick up the pace on privatisation
#Q1: For the banks, the hit on the books has been softer than 2020, still, the second wave has affected collections and recoveries at all levels. NBFCs, however, have been hit harder.
Analysis by Dinesh Unnikrishnan ⤵️
https://www.moneycontrol.com/news/business/analysis-npa-woes-continue-for-banks-nbfcs-in-q1-will-the-next-quarter-be-better-7230141.html?utm_source=telegram&utm_medium=social
Analysis by Dinesh Unnikrishnan ⤵️
https://www.moneycontrol.com/news/business/analysis-npa-woes-continue-for-banks-nbfcs-in-q1-will-the-next-quarter-be-better-7230141.html?utm_source=telegram&utm_medium=social
Moneycontrol
Analysis | NPA Woes Continue For Banks, NBFCs In Q1; Will The Next Quarter Be Better?
For the banks, the hit on the books has been softer than 2020, still, the second wave has affected collections and recoveries at all levels. NBFCs, however, have been hit harder
#EarningsWithMC: PVR has reported a net loss of Rs 219.4 crore in #Q1 ended June 2021 against a loss of Rs 225.7 crore in the same quarter last fiscal.
https://www.moneycontrol.com/news/business/earnings/pvr-q1-results-net-loss-narrows-to-rs-219-4-crore-revenue-up-at-rs-59-4-crore-7246321.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/business/earnings/pvr-q1-results-net-loss-narrows-to-rs-219-4-crore-revenue-up-at-rs-59-4-crore-7246321.html?utm_source=telegram&utm_medium=social
Moneycontrol
PVR Q1 Results: Net Loss Narrows To Rs 219.4 Crore, Revenue Up At Rs 59.4 Crore
PVR Q results: Earnings before interest, tax, depreciation and amortization loss narrowed to Rs 90.9 crore from Rs 116 crore in the year-ago period
#MCPro | Chances are #SBICards will not have to go through the FY21 pain all over again. Though the #Q1 didn’t have the fireworks, the signs of a sharp recovery are already there to see, writes Neha Dave.
https://www.moneycontrol.com/news/business/moneycontrol-research/sbi-cards-asset-quality-improves-in-q1-a-good-proxy-play-on-economic-recovery-7230331.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/business/moneycontrol-research/sbi-cards-asset-quality-improves-in-q1-a-good-proxy-play-on-economic-recovery-7230331.html?utm_source=telegram&utm_medium=social
Moneycontrol
SBI Cards Asset Quality Improves In Q1; A Good Proxy Play On Economic Recovery
The novelty factor, along with solid market position, growth prospects, strong parentage and superior return ratios, makes SBI Cards a worthy bet
#SBI has delivered a strong set of numbers in #Q1. The asset quality numbers remain at elevated levels yet the trend is in line with the industry 👇
What has happened on the bad loan segment? Dinesh Unnikrishnan takes a look at the numbers: https://www.moneycontrol.com/news/business/companies/analysis-sbi-gives-no-negative-surprises-in-q1-7277271.html?utm_source=telegram&utm_medium=social
What has happened on the bad loan segment? Dinesh Unnikrishnan takes a look at the numbers: https://www.moneycontrol.com/news/business/companies/analysis-sbi-gives-no-negative-surprises-in-q1-7277271.html?utm_source=telegram&utm_medium=social
Moneycontrol
Analysis | SBI Gives No Negative Surprises In Q1
SBI has logged steady numbers in Q1 in a tough market. Slippages remained high but that is largely in line with the industry trend.
#MarketsWithMC: Despite a 26% jump in #Q1 net profit, shares of #ManappuramFinance cracked as much as 15% in intraday trade today, pared some losses to close the day 12% lower.
Read: https://www.moneycontrol.com/news/business/markets/manappuram-finance-shares-crack-15-motilal-oswal-maintains-buy-call-post-q1-numbers-7315461.html?utm_source=telegram&utm_medium=social
Read: https://www.moneycontrol.com/news/business/markets/manappuram-finance-shares-crack-15-motilal-oswal-maintains-buy-call-post-q1-numbers-7315461.html?utm_source=telegram&utm_medium=social
Moneycontrol
Manappuram Finance Shares Crack 12%; Arihant Capital Downgrades Stock To Hold After Q1 Numbers
Brokerage firm Motilal Oswal Financial Services has maintained a buy call on the stock after the Q1 numbers, with a target price of Rs 220.
Pharmaceuticals have long been considered a defensive sector for investors during times of uncertainty. The sector did live up to those expectations.
Viswanath Pilla tells us what to expect in the second quarter at: https://www.moneycontrol.com/news/business/companies/pharma-rides-on-covid-second-wave-in-q1-us-generics-remain-a-concern-7361591.html?utm_source=telegram&utm_medium=social
#Pharma #COVID19 #EarningsWithMC #Q1
Viswanath Pilla tells us what to expect in the second quarter at: https://www.moneycontrol.com/news/business/companies/pharma-rides-on-covid-second-wave-in-q1-us-generics-remain-a-concern-7361591.html?utm_source=telegram&utm_medium=social
#Pharma #COVID19 #EarningsWithMC #Q1
Moneycontrol
Pharma Rides On Covid Second Wave In Q1; US Generics Remain A Concern
Companies expect sales in the Covid-19 portfolio to moderate in the second quarter even as sales of drugs in other categories increase. In the US generic drugs market, it could be another weak quarter
#Oil prices slid more than 1% today on concerns that a global supply surplus could swell in #Q1 following a coordinated release of #crude reserves among major consumers, led by the #US.
https://www.moneycontrol.com/news/business/markets/oil-skids-on-concerns-of-rising-surplus-in-q1-7763351.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/business/markets/oil-skids-on-concerns-of-rising-surplus-in-q1-7763351.html?utm_source=telegram&utm_medium=social
Moneycontrol
Oil Skids On Concerns Of Rising Surplus In Q1
Brent crude futures extended declines for a third session, falling 96 cents, or 1.2%, to $81.26 a barrel by 0130 GMT. U.S. West Texas Intermediate (WTI) crude was down $1.35, or 1.7%, at $77.04 a barrel. There was no settlement for WTI on Thursday because…
#Netflix has shattered hopes of a quick recovery after forecasting #Q1 subscriber growth, sending shares down nearly 20% and wiping out most of the remaining profits caused by the pandemic since 2020.
Read at
https://www.moneycontrol.com/news/business/netflix-q1-forecast-erases-much-of-stocks-pandemic-gains-7965231.html?utm_source=telegram&utm_medium=social
Read at
https://www.moneycontrol.com/news/business/netflix-q1-forecast-erases-much-of-stocks-pandemic-gains-7965231.html?utm_source=telegram&utm_medium=social
Moneycontrol
Netflix Q1 Forecast Erases Much Of Stock’s Pandemic Gains
Netflix said the competition “may affect our marginal growth somewhat” but added that it is still growing in every country where new streaming options have been launched.
#EarningsWithMC | Cipla's net profit for the April-June period is likely to be around Rs 813.4 crore, reflecting over 15% YoY growth, according to a consensus of brokerages polled by Moneycontrol.
Read more on Cipla #Q1 preview 👇
https://moneycontrol.com/news/business/earnings/cipla-q1-preview-steady-earnings-expected-strong-india-growth-to-offset-subdued-us-sales-11026131.html?utm_source=telegram&utm_medium=social
Read more on Cipla #Q1 preview 👇
https://moneycontrol.com/news/business/earnings/cipla-q1-preview-steady-earnings-expected-strong-india-growth-to-offset-subdued-us-sales-11026131.html?utm_source=telegram&utm_medium=social